Position in FATE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$213,081
-$113,130 QoQ
Shares Held
78,919
-60.1% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 156 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. FATE ranks #152 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in FATE
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,081 | 78,919 | Shares | Defined | 2026-08-12 | |
| 2024-12-31 | $326,211 | 197,704 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $648,931 | 185,409 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $545,316 | 166,255 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $965,789 | 131,579 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $198,152 | 52,982 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $78,571 | 37,062 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $100,978 | 21,214 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $3,308,309 | 327,880 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,308,704 | 236,890 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,829,123 | 235,235 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,400,489 | 216,675 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $10,507,518 | 179,585 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $8,146,305 | 137,444 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $11,296,065 | 130,154 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $10,703,823 | 129,822 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,129,987 | 12,427 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||